These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19548865)

  • 1. Use and safety of calcium channel blockers in obstetrics.
    Tranquilli AL; Giannubilo SR
    Curr Med Chem; 2009; 16(26):3330-40. PubMed ID: 19548865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium channel blockers in the management of preterm labor and hypertension in pregnancy.
    Papatsonis DN; Lok CA; Bos JM; Geijn HP; Dekker GA
    Eur J Obstet Gynecol Reprod Biol; 2001 Aug; 97(2):122-40. PubMed ID: 11451537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium channel blockers in cardiovascular pharmacotherapy.
    Godfraind T
    J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):501-15. PubMed ID: 24872348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
    Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with lercanidipine and enalapril in the management of the hypertensive patient: an update of the evidence.
    Antza C; Stabouli S; Kotsis V
    Vasc Health Risk Manag; 2016; 12():443-451. PubMed ID: 27895487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Calcium channel blockers in pregnancy].
    Tchobroutsky C
    Presse Med; 1996 Sep; 25(28):1297-300. PubMed ID: 8949791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
    Burnier M; Pruijm M; Wuerzner G
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular effects of calcium channel antagonists: new evidence.
    Richard S
    Drugs; 2005; 65 Suppl 2():1-10. PubMed ID: 16398057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of calcium-channel blockers in pregnancy.
    Lewis R; Sibai BM
    New Horiz; 1996 Feb; 4(1):115-22. PubMed ID: 8689266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The importance and safety of calcium antagonists in the treatment of hypertension in pregnant women.
    Grześk G; Wołowiec Ł; Walukiewicz M; Rogowicz D; Gilewski W; Banach J
    Pregnancy Hypertens; 2019 Apr; 16():85-88. PubMed ID: 31056164
    [No Abstract]   [Full Text] [Related]  

  • 11. [New calcium channel blockers for the treatment of hypertension].
    Tamargo J
    Hipertens Riesgo Vasc; 2017; 34 Suppl 2():5-8. PubMed ID: 29908667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigational calcium channel blockers for the treatment of hypertension.
    Tamargo J; Ruilope LM
    Expert Opin Investig Drugs; 2016 Nov; 25(11):1295-1309. PubMed ID: 27696904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of dihydropyridinic calcium channel blockers in the management of hypertension.
    Coca A; Mazón P; Aranda P; Redón J; Divisón JA; Martínez J; Calvo C; Galcerán JM; Barrios V; Roca-Cusachs I Coll A
    Expert Rev Cardiovasc Ther; 2013 Jan; 11(1):91-105. PubMed ID: 23259449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Results of a meta-analysis comparing the tolerability of lercanidipine and other dihydropyridine calcium channel blockers.
    Makarounas-Kirchmann K; Glover-Koudounas S; Ferrari P
    Clin Ther; 2009 Aug; 31(8):1652-63. PubMed ID: 19808126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High blood pressure and calcium antagonism.
    Palma-Gámiz JL
    Cardiology; 1997; 88 Suppl 1():39-46. PubMed ID: 9118167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular advantages of a third generation calcium antagonist. Symposium on lacidipine. Foreword.
    Zanchetti A
    Drugs; 1999; 57 Suppl 1():2 p preceding 1. PubMed ID: 10529077
    [No Abstract]   [Full Text] [Related]  

  • 17. Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients.
    Griffith TF; Chua BS; Allen AS; Klassen PS; Reddan DN; Szczech LA
    Am J Kidney Dis; 2003 Dec; 42(6):1260-9. PubMed ID: 14655199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Dihydropyridines for treatment of arterial hypertension].
    Bareza N; Gasser S; Toferer E; Scheer E; Pruthi D; Gasser R
    Pharm Unserer Zeit; 2005; 34(5):388-91. PubMed ID: 16180361
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy and safety of calcium channel blockers in hypertensive patients with concomitant left ventricular dysfunction.
    Parmley WW
    Clin Cardiol; 1992 Apr; 15(4):235-42. PubMed ID: 1563126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between L-type and N/L-type calcium channel blockers in the regulation of home blood-pressure variability in elderly hypertensive patients.
    Nozato S; Yamamoto K; Nozato Y; Takeda M; Hongyo K; Takeya M; Akasaka H; Takami Y; Takeya Y; Sugimoto K; Ito N; Rakugi H
    Hypertens Res; 2018 Apr; 41(4):290-298. PubMed ID: 29449705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.